homocysteine has been researched along with Berger Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Q; Huang, Q; Li, B; Li, J; Li, Z; Liu, G; Wei, X; Xu, Y; Yang, Q; Ye, H; Zhang, R | 1 |
| Liu, LJ; Lyu, JC; Shi, SF; Zhang, H; Zhang, YM; Zhou, XJ | 1 |
| Apeland, T; Jonsson, G; Mansoor, MA; Marti, HP; Slettan, A; Tariq, A; Weeraman, P | 1 |
3 other study(ies) available for homocysteine and Berger Disease
| Article | Year |
|---|---|
Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy.
Topics: Adult; Female; Glomerulonephritis, IGA; Homocysteine; Humans; Kidney Tubules; Male; Retrospective Studies | 2022 |
Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses.
Topics: Adult; Blood Pressure; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Homocysteine; Humans; Male; Mendelian Randomization Analysis; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged | 2020 |
Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy.
Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Dipeptides; Disease Progression; Female; Genetic Association Studies; Glomerulonephritis, IGA; Homocysteine; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Oxidoreductases; Polycystic Kidney, Autosomal Dominant; Polymorphism, Single Nucleotide; Prognosis; Risk; Superoxide Dismutase | 2018 |